Ryvu Therapeutics SA (RVU) — Long-term Investment Intensity
Ryvu Therapeutics SA (RVU) has a Long-term Investment Intensity of 0.0% as of September 2022. Long-term investments of zł21.60 represent 0.0% of total assets of zł169.84 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Ryvu Therapeutics SA net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ryvu Therapeutics SA Long-term Investment Intensity (2017–2021)
This chart shows how Ryvu Therapeutics SA's Long-term Investment Intensity has evolved across 4 annual periods from 2017 to 2021. As of September 2022, the intensity stands at 0.0%, reflecting long-term investments of zł21.60 against total assets of zł169.84 Million PLN. Also explore Ryvu Therapeutics SA assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Ryvu Therapeutics SA (2017–2021)
The table below presents the year-by-year Long-term Investment Intensity for Ryvu Therapeutics SA from 2017 to 2021, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Ryvu Therapeutics SA.
| Year | LT Investment Intensity | LT Investments (PLN) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.0% | zł29.40 | zł228.81 Million | ▲ +0.0 pp |
| 2020 | 0.0% | zł29.12 | zł295.64 Million | ▼ 0.0 pp |
| 2019 | 0.0% | zł23.75 | zł182.89 Million | ▲ +0.0 pp |
| 2017 | 0.0% | zł2.04 | zł103.57 Million | — |